Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
Saraswatarishta is a traditional Ayurvedic polyherbal fermented liquid formulation, classified as an 'Arishta,' which contains self-generated alcohol that acts as a preservative and a delivery vehicle for active herbal constituents. It is primarily used as a 'Medhya Rasayana' (nootropic or brain tonic) to enhance memory, concentration, and cognitive function. The formulation typically consists of approximately 18 herbal ingredients, including *Bacopa monnieri* (Brahmi), *Asparagus racemosus* (Shatavari), and *Terminalia chebula* (Haritaki). It is indicated for various neurological and psychological conditions, including Alzheimer's disease, Huntington's disease, depression, and anxiety. Some variants, known as Saraswatarishta with Gold, incorporate *Swarna Bhasma* (calcined gold) to enhance therapeutic efficacy in severe neurodegenerative cases. Research suggests it may work by reducing toxic protein aggregates, such as amyloid-beta plaques and polyglutamine (polyQ) repeats, and by modulating neurotransmitter activity.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Follow clinical development from study design and recruitment through results.
Explore development by indication, patient population, and geography.
Trace asset ownership, licensing agreements, and commercial partnerships.
Explore the patent landscape and regulatory exclusivity around an asset.
Compare development programs by target, modality, and indication.
Connect source evidence and development news to your research questions.
See how Gosset can support your research on Saraswatarishta.